​

Claritev (CTEV) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CTEV Stock Forecast

Claritev (CTEV) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $32.00, with a high of $38.00 and a low of $28.00. This represents a 47.67% increase from the last price of $21.67.

CTEV Stock Rating

Claritev stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (75.00%), 1 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 1 3 Strong Sell Sell Hold Buy Strong Buy

CTEV Price Target Upside V Benchmarks

TypeNameUpside
StockClaritev47.67%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Information Services Stocks 35.01%

Price Target Trends

1M3M12M
# Anlaysts-14
Avg Price Target-$28.00$32.25
Last Closing Price$21.67$21.67$21.67
Upside/Downside-29.21%48.82%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
May, 26321--6
Apr, 26221--5
Mar, 26221--5
Feb, 26221--5
Jan, 2621---3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 24, 2026Barclays$28.00$20.3037.93%29.21%
Feb 24, 2026Stan BerenshteynWells Fargo$30.00$23.2329.14%38.44%
Feb 24, 2026Guggenheim$38.00$23.2363.58%75.36%
Jan 08, 2026Stan BerenshteynWells Fargo$33.00$31.215.74%52.28%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 13, 2026CitigroupBuyBuyhold
Apr 24, 2026BarclaysOverweightinitialise
Feb 24, 2026GuggenheimBuyBuyhold
Oct 21, 2025CitigroupBuyupgrade
Aug 15, 2025Piper SandlerOverweightOverweighthold
May 29, 2025Piper SandlerOverweightupgrade

Financial Forecast

EPS Forecast

$-105 $-85 $-65 $-45 $-25 $-5 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-5.69$-101.92$-17.30--
Avg Forecast$-5.85$-80.71$-13.55$-10.42$-11.70
High Forecast$-5.80$-80.02$-13.44$-10.33$-11.60
Low Forecast$-5.90$-81.41$-13.67$-10.51$-11.80
Surprise %-2.74%26.28%27.68%--

Revenue Forecast

$900M $930M $960M $990M $1B $1B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$961.52M$930.62M$965.41M--
Avg Forecast$964.42M$935.49M$922.51M$960.61M$1.01B
High Forecast$970.80M$939.52M$926.08M$969.50M$1.02B
Low Forecast$958.05M$931.47M$918.95M$951.72M$1.01B
Surprise %-0.30%-0.52%4.65%--

Net Income Forecast

$-2B $-2B $-1B $-800M $-400M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-91.70M$-1.65B$-284.28M--
Avg Forecast$-94.54M$-1.30B$-218.83M$-167.75M$-190.46M
High Forecast$-93.72M$-1.29B$-216.95M$-166.86M$-187.37M
Low Forecast$-95.35M$-1.31B$-220.71M$-169.75M$-190.61M
Surprise %-3.00%26.28%29.91%--

CTEV Forecast FAQ

Is Claritev stock a buy?

Claritev stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Claritev is a favorable investment for most analysts.

What is Claritev's price target?

Claritev's price target, set by 4 Wall Street analysts, averages $32 over the next 12 months. The price target range spans from $28 at the low end to $38 at the high end, suggesting a potential 47.67% change from the previous closing price of $21.67.

How does Claritev stock forecast compare to its benchmarks?

Claritev's stock forecast shows a 47.67% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the healthcare information services stocks industry (35.01%).

What is the breakdown of analyst ratings for Claritev over the past three months?

  • May 2026: 50.00% Strong Buy, 33.33% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 40.00% Strong Buy, 40.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 40.00% Strong Buy, 40.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.

What is Claritev’s EPS forecast?

Claritev's average annual EPS forecast for its fiscal year ending in December 2026 is $-10.42, marking a -39.77% decrease from the reported $-17.3 in 2025. Estimates for the following years are.

What is Claritev’s revenue forecast?

Claritev's average annual revenue forecast for its fiscal year ending in December 2026 is $960.61M, reflecting a -0.50% decrease from the reported $965.41M in 2025. The forecast for.

What is Claritev’s net income forecast?

Claritev's net income forecast for the fiscal year ending in December 2026 stands at $-168M, representing a -40.99% decrease from the reported $-284M in 2025. Projections indicate .